Remove Big Data Remove Doctors Remove Life Science Remove Regulation
article thumbnail

AI, big data and real world evidence – the challenges and opportunities

pharmaphorum

One of the main reasons to use RWE is to counter a common criticism of the large phase 3 trials that for so long have been the ‘gold standard’ when developing drugs and gaining authorisations from regulators. BREATHE’s Jenni Quint said that the power is not just in information from wearables but the ability to link them with other data.

Big Data 132
article thumbnail

Medical Informatics and Rare Disease: a bridge between two worlds

pharmaphorum

Together, the webinar panellists explored the potential of medical informatics solutions and methods in rare disease research, studies, data optimisation, and usability to overcome these challenges, all whilst maintaining compliance with data protection regulations and a patient-centric approach.

Genome 105
article thumbnail

The rise of real-world evidence: unlocking the potential in EHRs

pharmaphorum

By extracting and reading unstructured information buried within the free text of clinical notes, Savana’s technology and clinical research methodology is enabling clinicians and health researchers around the world to analyse vast amounts of previously inaccessible clinical data. “We Fragmentation of information is our enemy.

Doctors 113